Connecticut 2023 2023 Regular Session

Connecticut Senate Bill SB00006 Introduced / Fiscal Note

Filed 03/30/2023

                    OFFICE OF FISCAL ANALYSIS 
Legislative Office Building, Room 5200 
Hartford, CT 06106  (860) 240-0200 
http://www.cga.ct.gov/ofa 
SB-6 
AN ACT CONCERNING UTILIZATION REVIEW AND HEALTH 
CARE CONTRACTS, HEALTH INSURANCE COVERAGE FOR 
NEWBORNS AND STEP THERAPY.  
 
Primary Analyst: NN 	3/29/23 
Contributing Analyst(s): SB, MP   
 
 
 
 
OFA Fiscal Note 
 
State Impact: 
Agency Affected Fund-Effect FY 24 $ FY 25 $ 
State Comptroller - Fringe 
Benefits 
GF - Potential 
Cost 
See Below See Below 
UConn Health Ctr. GF - Potential 
Cost 
At Least 
100,000 
At Least 
100,000 
Note: GF=General Fund 
  
Municipal Impact: 
Municipalities Effect FY 24 $ FY 25 $ 
Various Municipalities Potential 
Cost 
See Below See Below 
  
Explanation 
Sections 1 and 3 pertain to: (1) exemptions, under certain 
circumstances, for health care providers from certain utilization review 
processes used by health insurers and HMOs (also known as “gold-
carding”) and (2) shortening several of the maximum timeframes for 
insurers or independent review organizations (IRO) to notify insureds 
of their utilization review decisions.  
These sections do not result in a fiscal impact to the Insurance 
Department because: (1) the agency has the capacity and expertise to 
develop the regulations required by the bill and enforce its provisions, 
and (2) the bill specifies that the fees for IROs to conduct reviews of  2023SB-00006-R000337-FN.DOCX 	Page 2 of 2 
 
 
adverse determinations for such exemptions must be paid by the health 
insurer or HMO. 
Section 2 could result in a potential cost to the UConn Health Center 
beginning in FY 24, associated with establishing a secure system to 
electronically receive and respond to prospective and concurrent review 
requests. It is anticipated that the potential costs would exceed $100,000 
annually. 
Sections 4 and 5 extend the timeframe insurers must provide for 
notice of the birth of a newborn. This may result in a fiscal impact to the 
state and municipal plans to the extent that the number of claims 
increases. 
Sections 6 and 7 eliminate step therapy for certain behavioral health, 
or chronic, disabling, or life-threatening conditions or diseases resulting 
in no fiscal impact to the state employee and retiree health plan because 
step therapy is not frequently used within the plans. This may impact 
certain municipal plans that require step therapy.  
Section 8 of the bill prohibits the repeated use of utilization review 
for recurring health care services or prescription drugs. This decreases 
health carriers' ability to lower costs and in turn may impact state and 
municipal health plans through increased premiums.  
The Out Years 
The annualized ongoing fiscal impact identified above would 
continue into the future subject to inflation.